Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

44.92
Delayed Data
As of Jul 01
 -0.07 / -0.16%
Today’s Change
30.13
Today|||52-Week Range
52.58
-11.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues42.1M2.6M77.5M57.4M
 
 
 
 
 
Depreciation And Amortization88.0K--129.0K141.0K
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses7.1M8.0M7.2M8.7M
 
 
 
 
 
Research And Development4.6M5.2M4.5M5.4M
 
 
 
 
 
Total Operating Expenses7.2M8.0M7.3M8.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income34.9M-5.3M70.2M48.6M
 
 
 
 
 
Extraordinary Credit0.00--176.0K--
 
 
Extraordinary Charge-65.0K-----17.0K
 
 
 
Interest Expense On Debt------2.0K
 
 
Other Expenses-5.0K236.0K-2.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income34.9M-5.1M70.5M48.8M
 
 
 
 
 
Income Taxes-15.1M-48.0K-28.5M-20.0M
 
 
 
 
 
Net Income50.1M-5.0M42.0M28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.5M18.6M18.6M18.7M
 
 
 
 
 
Shares To Calculate EPS Diluted19.2M18.6M19.3M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS$2.61-$0.27$2.18$1.49
 
 
 
 
 
EPS Diluted$2.61-$0.27$2.18$1.49
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account